These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 7357760)

  • 1. Isolation and characterization of an acidic chemotactic factor from complement-activated human serum.
    Beebe DP; Ward PA; Spitznagel JK
    Clin Immunol Immunopathol; 1980 Jan; 15(1):88-105. PubMed ID: 7357760
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemotactic activity generated in human serum from the fifth component of complement by hydrogen peroxide.
    Shingu M; Nobunaga M
    Am J Pathol; 1984 Nov; 117(2):201-6. PubMed ID: 6388344
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled asbestos activates a complement-dependent chemoattractant for macrophages.
    Warheit DB; George G; Hill LH; Snyderman R; Brody AR
    Lab Invest; 1985 May; 52(5):505-14. PubMed ID: 3990243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Generation of a fibroblast chemotactic factor in serum by activation of complement.
    Postlethwaite AE; Snyderman R; Kang AH
    J Clin Invest; 1979 Nov; 64(5):1379-85. PubMed ID: 91624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chemotactic factor-induced low density neutrophils express enhanced complement (CR1 and CR3) receptors and increased complement-dependent cytotoxicity.
    Moqbel R; Richerson HB; MacDonald AJ; Walsh GM; Hartnell A; Walport MJ; Kay AB
    Clin Exp Immunol; 1987 Sep; 69(3):676-86. PubMed ID: 2959415
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A unique complement derived chemotactic factor for tumor cells.
    Romualdez AG; Ward PA
    Proc Natl Acad Sci U S A; 1975 Oct; 72(10):4128-32. PubMed ID: 172896
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial purification and characterization of eosinophil chemotactic factors from soluble extract of Fasciola species.
    Horii Y; Fujita K; Owhashi M
    Am J Vet Res; 1986 Jan; 47(1):123-6. PubMed ID: 3946890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A functional differentiation of human neutrophil granules: generation of C5a by a specific (secondary) granule product and inactivation of C5a by azurophil (primary) granule products.
    Wright DG; Gallin JI
    J Immunol; 1977 Sep; 119(3):1068-76. PubMed ID: 19531
    [No Abstract]   [Full Text] [Related]  

  • 9. Isolation of the leukocyte chemotactic factors in the extract of adult Metastrongylus apri.
    Sasaki O; Katsuno M
    Nihon Juigaku Zasshi; 1984 Jun; 46(3):357-61. PubMed ID: 6482130
    [No Abstract]   [Full Text] [Related]  

  • 10. Chemotactic factors associated with leukocyte emigration in immune tissue injury: their separation, characterization, and functional specificity.
    Hayashi H; Honda M; Shimokawa Y; Hirashima M
    Int Rev Cytol; 1984; 89():179-250. PubMed ID: 6381365
    [No Abstract]   [Full Text] [Related]  

  • 11. The chemotactic activity of normal and complement-activated serum as measured by the leading-front method using a Boyden chamber.
    Håkansson L; Venge P
    Scand J Immunol; 1984 Jan; 19(1):63-73. PubMed ID: 6367020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of the proenzyme form of the C1s subunit of the first complement component.
    Valet G; Cooper NR
    J Immunol; 1974 Jan; 112(1):339-50. PubMed ID: 4204604
    [No Abstract]   [Full Text] [Related]  

  • 13. A neutrophil chemotactic factor from human C'5.
    Ward PA; Newman LJ
    J Immunol; 1969 Jan; 102(1):93-9. PubMed ID: 5765461
    [No Abstract]   [Full Text] [Related]  

  • 14. A high molecular weight chemoattractant generated from C5 by ultracentrifugation of mouse serum without activation of complement.
    Leonard EJ; Skeel A
    Mol Immunol; 1983 Jun; 20(6):589-95. PubMed ID: 6410183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Isolation and partial characterization of an eosinophil chemotactic factor from metacestodes of Taenia taeniaeformis (ECF-Tt).
    Potter KA; Leid RW
    J Immunol; 1986 Mar; 136(5):1712-7. PubMed ID: 3512706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurement of complement activation in rabbit plasma or serum using monoclonal antibodies against C5a.
    Bergh K; Iversen OJ
    Scand J Immunol; 1989 Mar; 29(3):333-41. PubMed ID: 2470136
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of methylprednisolone on complement-mediated neutrophil activation during cardiopulmonary bypass.
    Tennenberg SD; Bailey WW; Cotta LA; Brodt JK; Solomkin JS
    Surgery; 1986 Aug; 100(2):134-42. PubMed ID: 3738745
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterizing a pH-switch anti-C5 antibody as a tool for human and mouse complement C5 purification and cross-species inhibition of classical and reactive lysis.
    Zelek WM; Stott M; Walters D; Harris CL; Morgan BP
    Immunology; 2018 Nov; 155(3):396-403. PubMed ID: 29981529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The isolation and partial characterization of neutrophil chemotactic factor from an oral bacterium, Streptococcus sanguis (author's transl)].
    Miyake Y
    Hiroshima Daigaku Shigaku Zasshi; 1981; 13(1):1-8. PubMed ID: 6945350
    [No Abstract]   [Full Text] [Related]  

  • 20. Purification of crystal induced chemotactic factor from human neutrophils.
    Bhatt AK; Spilberg I
    Clin Biochem; 1988 Dec; 21(6):341-5. PubMed ID: 3233746
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.